Wall Street brokerages predict that Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Rating) will report earnings of ($1.29) per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Arcturus Therapeutics’ earnings, with estimates ranging from ($1.76) to ($1.02). Arcturus Therapeutics posted earnings of ($2.15) per share in the same […]
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in.
Arcturus Therapeutics Appoints Jing Marantz, M D , Ph D , M B A to its Board of Directors news8000.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news8000.com Daily Mail and Mail on Sunday newspapers.